Montreal EpiTerapia

Who we are and what we’re doing?
- Montreal EpiTerapia is a Canadian incorporated company whose goal is to promote and distribute novel diagnostic and therapeutics based on the new science of epigenetics in emerging markets particularly in Eurasia.
What are epigenetic marks?
- Genes are marked by small chemicals called DNA methylation. In cancer these methylation marks are changed in specific genes. By mapping the methylation state of these genes we can determine whether the DNA comes from a cancer cell or a normal cell.
What does methylation of DNA do?
- Methylation is the punctuation which turns DNA into a language.
What is our company's strategy
- Montreal EpiTerapia plans to establish the diagnostic laboratories and distribution centre in Kazakhstan, India and Georgia that will provide epigenetic and next-generation based diagnostic.

News & events

Keep up to date with Montreal EpiTerapia's latest research news and upcoming special events.

Jan 19, 2018
Clinical trials on early detection of colorectal, prostate and breast cancers.

read more >>
Jan 07, 2017
Experimental addiction treatment in Canada

read more >>
Jan 16, 2018
The signature of liver cancer in host DNA methylation in peripheral white blood cells and T cells

read more >>

{mosmap}